期刊文献+

转移性前列腺癌局部治疗的临床进展

The clinical progress of the local treatment for metastatic prostate cancer
原文传递
导出
摘要 近期临床研究表明原发肿瘤的局部治疗有助于提高转移性前列腺癌患者的肿瘤特异生存率和总生存率。与淋巴结转移不同,伴有远处骨转移的前列腺癌患者能否受益尚缺乏高级别的随机对照试验数据,同时影响患者预后的相关因素也需进一步探讨。多种局部治疗方式与系统治疗如何有效联合也是目前研究的热点。 Recent clinical research shows that the local treatment of primary tumor c'an improve cancer-specific-survival and overall-survival for metastatic prostate cancer patients. Differ with lymph node metastasis, there is not enough high-level randomized controlled trial data to decide whether the prostate cancer patients with bone metastasis will be benefited from local treatment, meanwhile, it also needs to fig- ure out the factors influencing prognosis of patients. How to efficiently combine multi local treatment with system treatment is a current research hot spot as well.
出处 《中国医师杂志》 CAS 2017年第11期1749-1752,共4页 Journal of Chinese Physician
基金 国家自然科学基金项目(81471761)
关键词 前列腺肿瘤/继发性/治疗 综述 Prostatic neoplasms/SC/TH Review
  • 相关文献

参考文献2

二级参考文献21

  • 1李鎏勋,龙智,何乐业.阿比特龙治疗转移性去势抵抗性前列腺癌1例[J].中南大学学报(医学版),2015,40(6):688-692. 被引量:7
  • 2郝捷.2012年中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:1 -10. 被引量:9
  • 3那彦群,叶章群,孙颖浩,等.中国泌尿外科疾病诊断治疗指南(2014版)[M].北京:人民卫生出版社,2014:528. 被引量:30
  • 4Center MM, Jemal A, Lortet-Tieulent J, et al. Internationl variation in prostate cancer incidence and mortality rates [ J 1. European urology, 2012,61 ( 6): 1079-1092. 被引量:1
  • 5Siegel R, Ma J, Zou Z, et al.Cancer statistics, 2014 [ J ].CA Cancer J Clin,2014,64(1) :9-29. 被引量:1
  • 6Bray F, Lortet-Tieulent J, Ferlay J, et al. Prostate cancer incidence and mortalily trends in 37 european courtries: An overview [ J ]. European journal of cancer, 2010, 46 (17) :3040-3052. 被引量:1
  • 7Agarwal DK, Costello A J, Peters J, et al. Differential re- sponse of prostate specific to testosterone surge after lu- teinizing hormone-releasing hormone analogue in prostate cancer and benign protatic hypertrophy [ J ]. BJU Int, 2000,85 (6) : 690-695. 被引量:1
  • 8Oh WK. The evolving role of estrogen therapt in prostate cancer[ J] .Clin Prostate Cancer, 2002,1 (2) : 81-$9. 被引量:1
  • 9Chi KN, Bjartell A, Dearnaley D, et al. Castration-resist- ant prostate cancer: from new pathophysiology to newtreatment targets [ J ]. Eur Urol, 2009,56 (4) : 594-605. 被引量:1
  • 10Scher HI, Beer TM, Higano CS, et al.Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study [ J ]. Lancet, 2010, 375 ( 9724 ) : 1437- 1446. 被引量:1

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部